PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
PDS Biotechnology Corporation announced a conference call and webcast for March 30, 2026, to report its fourth quarter and full-year 2025 financial results. The company will also provide updates on its pivotal clinical trials, including its lead immunotherapy program targeting HPV16-positive head and neck cancers using PDS0101 in combination therap…